APA (7th ed.) Citation

Decramer, M., Rutten-van Mölken, M., Dekhuijzen, P., Troosters, T., van Herwaarden, C., Pellegrino, R., . . . al., e. (2005). Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): A randomised placebo-controlled trial: The Lancet 2005;365(9470):1552–60. Respiratory Medicine: COPD Update, 1(2), 66. https://doi.org/10.1016/j.rmedu.2005.09.021

Chicago Style (17th ed.) Citation

Decramer, M., et al. "Effects of N-acetylcysteine on Outcomes in Chronic Obstructive Pulmonary Disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): A Randomised Placebo-controlled Trial: The Lancet 2005;365(9470):1552–60." Respiratory Medicine: COPD Update 1, no. 2 (2005): 66. https://doi.org/10.1016/j.rmedu.2005.09.021.

MLA (9th ed.) Citation

Decramer, M., et al. "Effects of N-acetylcysteine on Outcomes in Chronic Obstructive Pulmonary Disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): A Randomised Placebo-controlled Trial: The Lancet 2005;365(9470):1552–60." Respiratory Medicine: COPD Update, vol. 1, no. 2, 2005, p. 66, https://doi.org/10.1016/j.rmedu.2005.09.021.